Point-of-Care Infectious Disease Diagnostics Testing Market

A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.

Point-of-Care Infectious Disease Diagnostics Testing Market contains market size and forecasts of Point-of-Care Infectious Disease Diagnostics & Testing in Global, including the following market information:

Global Point-of-Care Infectious Disease Diagnostics & Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Point-of-Care Infectious Disease Diagnostics & Testing market was valued at 1054.5 million in 2021 and is projected to reach US$ 1500.4 million by 2028, at a CAGR of 5.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

HIV POC Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Point-of-Care Infectious Disease Diagnostics & Testing include Abbott, Thermo Fisher Scientific Inc, Roche, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health and Quest Diagnostics Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Point-of-Care Infectious Disease Diagnostics & Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Point-of-Care Infectious Disease Diagnostics & Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Percentages, by Type, 2021 (%)

HIV POC

Clostridium difficile POC

HBV POC

Pneumonia or Streptococcus associated infections

Respiratory syncytial virus (RSV) POC

HPV POC

Influenza/Flu POC

Other Infectious Disease POC

Global Point-of-Care Infectious Disease Diagnostics & Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Home

Assisted Living Healthcare Facilities

Laboratories

Others

Global Point-of-Care Infectious Disease Diagnostics & Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Point-of-Care Infectious Disease Diagnostics & Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Point-of-Care Infectious Disease Diagnostics & Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott

Thermo Fisher Scientific Inc

Roche

Siemens Healthineers

BD & Company

Chembio Diagnostics Inc.

Trinity Biotech

Cardinal Health

Quest Diagnostics Inc.

Bio-Rad Labs Inc.

bioM?rieux SA

Sight Diagnostics Ltd.

Gene POC

Trivitron Healthcare

OJ-Bio Ltd.

Ortho-Clinical Diagnostics